-
Signature
-
/s/ Kerry Acocella, Attorney-in-Fact
-
Stock symbol
-
DDOG
-
Transactions as of
-
Oct 11, 2024
-
Transactions value $
-
-$4,294,674
-
Form type
-
4
-
Date filed
-
10/16/2024, 04:20 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
DDOG |
Class A Common Stock |
Conversion of derivative security |
$51.7K |
+33.3K |
+10.61% |
$1.55 |
347K |
Oct 11, 2024 |
Direct |
F1 |
transaction |
DDOG |
Class A Common Stock |
Sale |
-$4.35M |
-33.3K |
-9.59% |
$130.39 |
314K |
Oct 11, 2024 |
Direct |
F2, F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
DDOG |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-33.3K |
-19.14% |
$0.00 |
141K |
Oct 11, 2024 |
Class B Common Stock |
33.3K |
$1.55 |
Direct |
F4 |
transaction |
DDOG |
Class B Common Stock |
Options Exercise |
$0 |
+33.3K |
+213.63% |
$0.00 |
48.9K |
Oct 11, 2024 |
Class A Common Stock |
33.3K |
|
Direct |
F1 |
transaction |
DDOG |
Class B Common Stock |
Conversion of derivative security |
$0 |
-33.3K |
-68.12% |
$0.00 |
15.6K |
Oct 11, 2024 |
Class A Common Stock |
33.3K |
|
Direct |
F1 |
holding |
DDOG |
Class B Common Stock |
|
|
|
|
|
92.4K |
Oct 11, 2024 |
Class A Common Stock |
92.4K |
|
By Trust |
F1, F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: